227 related articles for article (PubMed ID: 19328452)
1. Commentary on "a roadmap for the prevention of dementia II: Leon Thal symposium 2008." The megacommunity approach to Alzheimer's disease.
Van Lee R; Meagher B; Fritz P; Penfield S
Alzheimers Dement; 2009 Mar; 5(2):163-5. PubMed ID: 19328452
[TBL] [Abstract][Full Text] [Related]
2. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Centers of excellence in Alzheimer's disease: it is time to better integrate patient care and clinical research to improve the prevention and treatment of Alzheimer's disease.
Doody RS
Alzheimers Dement; 2009 Mar; 5(2):133-6. PubMed ID: 19328443
[TBL] [Abstract][Full Text] [Related]
3. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Innovations in care that advance Alzheimer's disease drug development.
Foster NL; Andersen TC; Zamrini EY
Alzheimers Dement; 2009 Mar; 5(2):159-62. PubMed ID: 19328451
[TBL] [Abstract][Full Text] [Related]
4. Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." A proposal to increase participation in Alzheimer's disease clinical trials.
Ryan JM; Schneider G; Jacobsen JS
Alzheimers Dement; 2009 Mar; 5(2):140-2. PubMed ID: 19328445
[No Abstract] [Full Text] [Related]
5. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Primary prevention of dementia in Alzheimer's disease: a perspective from prevention research in cardiovascular disease and stroke.
Fillit H; Nash DT; Shineman D
Alzheimers Dement; 2009 Mar; 5(2):149-53. PubMed ID: 19328448
[No Abstract] [Full Text] [Related]
6. Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Who may benefit from disease-modifying studies in Alzheimer's disease?
Gauthier S; Poirier J
Alzheimers Dement; 2009 Mar; 5(2):147-8. PubMed ID: 19328447
[No Abstract] [Full Text] [Related]
7. Commentary on "a roadmap for the prevention of dementia: the inaugural Leon Thal Symposium." An impending prevention clinical trial for Alzheimer's disease: roadmaps and realities.
Roses AD
Alzheimers Dement; 2008 May; 4(3):164-6. PubMed ID: 18631961
[No Abstract] [Full Text] [Related]
8. Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." Establishing a national biomarker database: utility and incentives.
Cummings JL
Alzheimers Dement; 2009 Mar; 5(2):108-13. PubMed ID: 19328437
[No Abstract] [Full Text] [Related]
9. Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." A federally funded corporation for the prevention and treatment of cognitive impairment and brain aging.
Schneider LS
Alzheimers Dement; 2009 Mar; 5(2):172-9. PubMed ID: 19328454
[No Abstract] [Full Text] [Related]
10. Letter to the editor on the 2009 Leon Thal Symposium.
Fortier D
Alzheimers Dement; 2010 Mar; 6(2):195-6. PubMed ID: 20298982
[No Abstract] [Full Text] [Related]
11. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Recruitment of participants for Alzheimer's disease clinical trials: the role of trust in caregivers, clinical researchers, regulatory authorities, and industry sponsors.
Snyder PJ; Papp KV; Bartkowiak J; Jackson CE; Doody RS
Alzheimers Dement; 2009 Mar; 5(2):122-4. PubMed ID: 19328439
[TBL] [Abstract][Full Text] [Related]
12. Commentary on "Developing a national strategy to prevent dementia: Leon Thal Symposium 2009." Methodologic considerations for preventing Alzheimer's disease by 2020.
Shankle WR
Alzheimers Dement; 2010 Mar; 6(2):145-6. PubMed ID: 20298977
[No Abstract] [Full Text] [Related]
13. Commentary on "Developing a national strategy to prevent dementia: Leon Thal Symposium 2009." The rationale for a National Institutional Review Board for neurodegenerative diseases.
Snyder PJ
Alzheimers Dement; 2010 Mar; 6(2):135-7. PubMed ID: 20298974
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease: research advances and medical reality.
Seiguer E
Issue Brief (Commonw Fund); 2005 Jul; (828):1-10. PubMed ID: 16189900
[TBL] [Abstract][Full Text] [Related]
15. Advancing Alzheimer's disease drug review as a national priority.
Perry DP
Alzheimers Dement; 2009 Mar; 5(2):180-1. PubMed ID: 19328455
[TBL] [Abstract][Full Text] [Related]
16. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Facilitating Alzheimer's disease drug development in the United States.
Aisen PS
Alzheimers Dement; 2009 Mar; 5(2):125-7. PubMed ID: 19328440
[No Abstract] [Full Text] [Related]
17. A roadmap for the prevention of dementia II: Leon Thal Symposium 2008.
Khachaturian ZS; Snyder PJ; Doody R; Aisen P; Comer M; Dwyer J; Frank RA; Holzapfel A; Khachaturian AS; Korczyn AD; Roses A; Simpkins JW; Schneider LS; Albert MS; Egge R; Deves A; Ferris S; Greenberg BD; Johnson C; Kukull WA; Poirier J; Schenk D; Thies W; Gauthier S; Gilman S; Bernick C; Cummings JL; Fillit H; Grundman M; Kaye J; Mucke L; Reisberg B; Sano M; Pickeral O; Petersen RC; Mohs RC; Carrillo M; Corey-Bloom JP; Foster NL; Jacobsen S; Lee V; Potter WZ; Sabbagh MN; Salmon D; Trojanowski JQ; Wexler N; Bain LJ
Alzheimers Dement; 2009 Mar; 5(2):85-92. PubMed ID: 19328434
[TBL] [Abstract][Full Text] [Related]
18. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." A national registry to identify a cohort for Alzheimer's disease prevention studies.
Sabbagh MN; Tariot PN
Alzheimers Dement; 2009 Mar; 5(2):128-9. PubMed ID: 19328441
[No Abstract] [Full Text] [Related]
19. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Alzheimer's disease translational research programs at the National Institute on Aging.
Petanceska S; Ryan L; Silverberg N; Buckholtz N
Alzheimers Dement; 2009 Mar; 5(2):130-2. PubMed ID: 19328442
[No Abstract] [Full Text] [Related]
20. Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." Comments from abroad.
Korczyn AD
Alzheimers Dement; 2009 Mar; 5(2):157-8. PubMed ID: 19328450
[No Abstract] [Full Text] [Related]
[Next] [New Search]
